Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 176.62 M183.04 M180.7 M194.62 M148.85 M 707.21 M Research & development ————— — Operating income 286.65 M284.44 M295.92 M268.2 M141.79 M 990.36 M Non-Operating Income, Total -1.56 M-7.69 M-12 M-16.46 M-2.83 M -38.99 M Interest expense, net of interest capitalized 665 K667 K668 K732 K800 K 2.87 M Non-Operating Income, excl. Interest Expenses -665 K-667 K-668 K-732 K-800 K -2.87 M Unusual income/expense -1.56 M-7.69 M-12 M-16.46 M-2.83 M -38.99 M Pretax income 1.72 B1.85 B1.92 B1.91 B1.24 B 6.91 B Equity in earnings 1.98 M326 K1.25 M1.31 M2.88 M 5.77 M Taxes 64.84 M67.28 M67.94 M50.72 M30.25 M 216.19 M Non-controlling/minority interest 265 K2.41 M3.01 M3.08 M1.8 M 10.3 M After tax other income/expense ————— — Net income before discontinued operations 213.47 M193.58 M201.44 M174.02 M98.63 M 667.66 M Discontinued operations ————— — Net income 213.47 M193.58 M201.44 M174.02 M98.63 M 667.66 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 213.47 M193.58 M201.44 M174.02 M98.63 M 667.66 M Basic earnings per share (Basic EPS) 2.111.942.051.81.03 6.82 Diluted earnings per share (Diluted EPS) 2.071.922.011.771.01 6.71 Average basic shares outstanding 101.25 M99.54 M98.44 M99.07 M96.03 M — Diluted shares outstanding 103.02 M100.92 M100.05 M100.71 M97.53 M — EBITDA 295.67 M294.59 M306.32 M278.81 M152.53 M 1.03 B EBIT 286.65 M284.44 M295.92 M268.2 M141.79 M 990.36 M Cost of revenue 1.43 B1.56 B1.62 B1.64 B1.1 B 5.91 B Other cost of goods sold 14.88 M6.75 M7.19 M08.18 M 22.13 M Depreciation & amortization (cash flow) 9.02 M10.15 M10.4 M10.61 M10.73 M 41.9 M